Epirubicin
Leptomeningeal Metastasis
Medical College of WisconsinPhase 2Active
B
58/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 81/ 100
Competitive context
27 Active assets in the Leptomeningeal Metastasis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Inno-206 Fudan University | Phase 4 | BB |
METHOTREXATE The First Affiliated Hospital with Nanjing Medical University | Phase 4 | BB |
DEXAMETHASONE Shanghai Cancer Hospital, China | Phase 2 | B |
Durvalumab Hui Bu | Phase 4 | B |
Endostar Hui Bu | Phase 4 | B |
View all 34 →
Same molecule, other indications
Epirubicin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →